Sign in
Explore the registryTrack Crizanlizumab's trials

STAND

Study of Two Doses of Crizanlizumab Versus Placebo in Adolescent and Adult Sickle Cell Disease Patients

Crizanlizumab (SEG101)OngoingActive not recruitingPhase 3Open NCT03814746 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…